Epitomics

Epitomics, a subsidiary of Abcam, specializes in providing high-quality protein research tools to life scientists globally. The company offers an extensive range of over 118,000 products, including antibodies, kits, proteins, and other reagents essential for scientific research. Epitomics serves a diverse clientele, including academic institutions, pharmaceutical companies, and biotech firms, operating primarily in the life sciences market. The business model revolves around the sale of these research tools, custom antibody development, and commercial partnerships aimed at advancing diagnostic and therapeutic discoveries. Revenue is generated through direct sales, large volume orders, and custom solutions tailored to meet specific research needs. Epitomics also supports its clients with online materials, protocols, and global scientific support to ensure the effective use of their products.

Keywords: protein research tools, antibodies, kits, reagents, life sciences, custom solutions, commercial partnerships, diagnostic discovery, therapeutic discovery, scientific support.